Site icon

Second Cohort Announced for Pfizer Healthcare Hub: London

Second Cohort Announced for Pfizer Healthcare Hub: London

Pfizer has announced that Medopad, Perfect Ward and Inhealthcare have been selected to be part of the Pfizer Healthcare Hub: London.

The winners will have access to Pfizer’s network of partners, and can now begin to scope how they will use their respective grants over the next 12 months.

The chosen start-ups were selected by a panel of Pfizer UK leaders and invited judges including Vice President of the University of Swansea, Prof. Marc Clement and Chief Clinical Information Officer at Taunton & Somerset NHS Foundation Trust, Dr Luke Gompels.

Dr Hamish Graham, Pfizer Healthcare Hub: London Manager commented, “The broad array of innovative technology presented to us by the different start-ups at the pitch day was a real privilege to see. The three winners really stood out due to their ability to show the impact of the technology on the healthcare service and the lives of patients. We are looking forward to collaborating on some exciting projects in the next 12 months to help bring the benefits of their technology to more patients in the UK.”

About the winners:

Mridula Pore, head of partnerships from Medopad said, “The Pfizer Healthcare Hub: London initiative is a really important program to build within the healthcare ecosystem to really bring corporates and start-ups together. Collaborating is exactly what we do to create value for patients and that’s what we want to continue to do, but on a much bigger level with this partnership with Pfizer.”

Bryn Sage, chief executive of Inhealthcare, said, “It’s fantastic to be working with the Pfizer Healthcare Hub: London. We really value the extra support and guidance to help us to build on our achievements to date. We’re passionate about keeping people out of hospital; scaling our technology will help us to transform the health and care service and allow more people to be cared for on-the-go.”

Jonathan Knight, Founder & CEO Perfect Ward commented, “We’re excited to be able to work with the expert mentors at Pfizer who so clearly understand patients and clinicians. Their valuable input will help us to develop, improve and grow, as well as help us deliver our mission and goals.”

Exit mobile version